Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Verrica Pharmaceuticals Inc. (VRCA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.0000+0.0450 (+2.30%)
At close: 04:00PM EDT
2.0200 +0.02 (+1.00%)
After hours: 07:55PM EDT
Advertisement
Sign in to post a message.
  • N
    Npp
    I am trapped at an average of $2.28. I averaged down what I could and am worried this is heading to 0. I haven't seen Ted do anything to salvage his relationship with shareholders and I doubt he's going to. I am hoping ofr the best.
    Bullish
  • S
    Steve
    I am not seeing any 483s against Sterling on the FDA site link below. The FDA gave the CRL based on deficiencies not even related to the Verrica product. This pattern of smacking down biotechs with good products has been going on since the last inauguration. They pull CRL excuses from a hat.
    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-references/inspection-observations
  • n
    nxtrade
    Sold for a loss. No way was my average going to be seen again. I believe the company has 3 months left before it hits 0. Not much hope left here. The chances of this going passed $2.50 again are slim to none, Many here will never recover or make it out.
    Bearish
  • j
    jon
    I agree with a lot here. I am not happy with how things went down. Unbelievable 3 big back to back selling days. Here I am averaged down to $2.13 and just praying for a turnaround. feels like just yesterday we were in the 6's. Hope management is held accountable.
    Bullish
  • b
    bluehorseshoe999
    End of road!

    I did some re-assessment and figure on mgmt contribution (negative)!

    TP for next year is around 1 with cash burn. No guarantees with NDA being accepted in Jan 2023 and drug approval in June 2023. NDA has been rejected twice for same reason and same thing could happen again!

    Even with approval, a massive dilution expected with low PPS share so it does not look good. ALmost guaranteed 1 or less by early next year. Should bounce here around 2 for while as MMs unload shares for funds!

    GLTA in stock casino!
  • D
    Dragan
    No money, huge debt. Going under 2 for sure...
  • S
    Salubrix
    If you thought yesterday's volume was high....over one million shares as of first few minutes of trading
  • n
    nxtrade
    I am in at $3.50 and sort of terrified. Anyone else in a similar boat? I will go down with the ship to 0 at this point shares are not worth much anyway.
  • V
    VINCE
    WEST CHESTER, PA – May 28, 2021 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Prescription Drug User Fee Act (PDUFA) goal date has been extended by three months to September 23, 2021.

    The FDA extended the PDUFA goal date to allow the Agency to have additional time to review information submitted by Verrica, including its training program and distribution model, in response to comments from the agency regarding the Company’s human factors study. On May 26, 2021, the FDA informed Verrica that the information submitted has been designated a major amendment, which allows FDA to take an additional three months to review the submitted information.

    “We remain confident in VP-102 as a potential treatment option for patients with molluscum,” said Ted White, Verrica’s President and Chief Executive Officer. “Importantly, the FDA has recently completed one of the two pre-approval inspections required for approval. We look forward to our continued productive discussions with the FDA as it completes its review of our VP-102 NDA.”
  • Y
    Yankees Win
    This company has a lot of debt, and after today's news, chances of going bankrupt are really high.
  • j
    jon
    Most investors here will never recover thanks to Paul and his team. The chances this sees $2.30 again are slim to none. I only see reverse split and dilution. Hoping to escape before it is too late.
  • M
    Metehan
    when will we reach $10+? Today or tomorrow
  • F
    Farah
    Waiting on FDA approval? Anyone have an update?
  • L
    L.R.
    Looking like a positive buying opportunity. The manufacturing issues will be resolved and the NDA will be approved in 6-12 months.
  • S
    Salubrix
    Full PDF on website news release. May 24th 8:04 PM "Verrica has been advised that PAI (Pre-Approval Inspection) was conducted at Sterling and is not aware of any reported observations related to the PAI of VP-102 operations

    Review Division had advised Verrica that the review of NDA was completed and label was ready to be communicated, except for Sterling’s classification status

    Verrica has been notified that Sterling is on OAI (Official Action Indicated) status
  • s
    stocktracker000
    On a final note, I fill sad for millions of patient out there that suffer from this disease. There no death issue and just manufacturing issue left due to bad CMO. There should be expedited path for drug to get approve after only manufacturing facility is inspected. It would be win-win situation for everybody. In the mean time patient do not have access to drug that will help them...

    Someone contact FDA and fix this type of situation. This is not a manufacturing problem. NDA was rejected based on a technicality. This should be corrected for future NDAs with expedited path for re-submission.

    Good Luck to all and do your due diligence always...
  • S
    Shroom
    Interesting action. A short attack by Vince posting a year old article and there is a seeking alpha author claiming that a CRL is in hand. That coupled with no news yet is interesting. The lack of an announcement makes me lean the shorts are correct but lets see what happens.
  • s
    stocktracker000
    if U shorted, cover tomorrow. Most of margin calls covered today and sold....

    Tomorrow should see some accumulation and more selling as those funds that jump off first and then look get out...

    Only buy if U plan to hold till next year and keep it small (5-10% of UR portfolio)...

    My view is that PPS will languish over the summer around 2 and then start climbing in the fall in anticipation of new PFUDA date...

    Good Luck to all and do your due diligence always...
    Neutral
  • A
    Android
    bid/ask spread is crazy in AH 4.18/5.5... someone is playing games
  • N
    Npp
    No way out of this mess. Hold Ted accountable.
Advertisement
Advertisement